期刊
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
卷 38, 期 4, 页码 571-573出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RCT.0000000000000086
关键词
ferumoxytol; ultrasmall superparamagnetic iron oxide nanoparticles; mimic hemosiderosis; magnetic resonance imaging (MRI)
Ferumoxytol is a parenteral iron therapy that the Food and Drug Administration recently approved for the treatment of iron-deficiency anemia. The form of the iron, ultrasmall superparamagnetic iron oxide nanoparticles, causes T1, T2, and T2* shortening on magnetic resonance imaging, which can mimic hemosiderosis. We report such a case, with laboratory findings that demonstrate normal iron stores, and discuss the potential implications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据